Home Cart Sign in  
Chemical Structure| 196612-93-8 Chemical Structure| 196612-93-8

Structure of Falnidamol
CAS No.: 196612-93-8

Chemical Structure| 196612-93-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BIBX 1382 is a potent, selective inhibitor of EGFR tyrosine kinase (IC50 = 3 nM) and displays > 1000-fold lower potency against ErbB2 (IC50 = 3.4 μM) and a range of other related tyrosine kinases (IC50 > 10 μM).

Synonyms: Bibx 1382; BIBX 1382 BS

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Falnidamol

CAS No. :196612-93-8
Formula : C18H19ClFN7
M.W : 387.84
SMILES Code : CN1CCC(NC2=NC=C(N=CN=C3NC4=CC=C(F)C(Cl)=C4)C3=N2)CC1
Synonyms :
Bibx 1382; BIBX 1382 BS
MDL No. :MFCD09838900

Safety of Falnidamol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Falnidamol

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293-ABCB1 cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on HEK293-ABCB1 cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883
HEK293-Vector cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on HEK293-Vector cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883
SW620-Adr cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on SW620-Adr cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883
SW620 cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on SW620 cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883
HELA-Col cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on HELA-Col cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883
HELA cells 5 µM 72 hours To evaluate the toxicity of Falnidamol on HELA cells and its ability to reverse ABCB1-mediated multidrug resistance PMC11707883

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice HELA-Col xenograft model Oral 30 mg/kg Every 3 days for 15 days To evaluate the in vivo efficacy of Falnidamol in reversing ABCB1-mediated multidrug resistance PMC11707883
C57BL/6 male mice Healthy mice Tail vein injection 40mg/kg Single injection To test the effect of EGFR blocker BIBX1382 on hepatic TG secretion rate, results showed that BIBX1382 significantly suppressed hepatic TG secretion PMC6452438

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.89mL

2.58mL

1.29mL

25.78mL

5.16mL

2.58mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories